A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice (Dec, 10.1016/S2666-5247(21)00331-1, 2021)

被引：0
|
作者：
Zhao
机构：
来源：
LANCET MICROBE | 2022年 / 3卷 / 03期
关键词：
D O I：
10.1016/S2666-5247(22)00001-5
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E170 / E170
页数：1
相关论文
共 50 条
  • [1] A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
    Zhang, Rong
    Li, Dedong
    Xu, Kun
    Yang, Chenxi
    Luo, Tingrong
    Zhao, Xin
    Gao, George F.
    LANCET MICROBE, 2022, 3 (03): : E165 - E166
  • [2] Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study (Mar, 10.1016/S2666-5247(21)00025-2, 2021)
    Chia, W. N.
    Zhu, F.
    Ong, S. W. X.
    LANCET MICROBE, 2021, 2 (05): : E179 - E179
  • [3] Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains
    Xiao, Chanchan
    Su, Jun
    Zhang, Chanjuan
    Huang, Boya
    Mao, Lipeng
    Ren, Zhiyao
    Bai, Weibin
    Li, Huayu
    Lei, Guomin
    Zheng, Jingshan
    Chen, Guobing
    Liang, Xiaofeng
    Qiu, Congling
    VIRUSES-BASEL, 2022, 14 (09):
  • [4] Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
    Souza, William M.
    Amorim, Mariene R.
    Sesti-Costa, Renata
    Coimbra, Lais D.
    Brunetti, Natalia S.
    Toledo-Teixeira, Daniel A.
    Souza, Gabriela F. de
    Muraro, Stefanie P.
    Parise, Pierina L.
    Barbosa, Priscilla P.
    Bispo-dos-Santos, Karina
    Mofatto, Luciana S.
    Simeoni, Camila L.
    Claro, Ingra M.
    Duarte, Adriana S. S.
    Coletti, Thais M.
    Zangirolami, Audrey B.
    Costa-Lima, Carolina
    Gomes, Arilson B. S. P.
    Buscaratti, Lucas, I
    Sales, Flavia C.
    Costa, Vitor A.
    Franco, Lucas A. M.
    Candido, Darlan S.
    Pybus, Oliver G.
    de Jesus, Jaqueline G.
    Silva, Camila A. M.
    Ramundo, Mariana S.
    Ferreira, Giulia M.
    Pinho, Mariana C.
    Souza, Leandro M.
    Rocha, Esmenia C.
    Andrade, Pamela S.
    Crispim, Myuki A. E.
    Maktura, Grazielle C.
    Manuli, Erika R.
    Santos, Magnun N. N.
    Camilo, Cecilia C.
    Angerami, Rodrigo N.
    Moretti, Maria L.
    Spilki, Fernando R.
    Arns, Clarice W.
    Addas-Carvalho, Marcelo
    Benites, Bruno D.
    Vinolo, Marco A. R.
    Mori, Marcelo A. S.
    Gaburo, Nelson
    Dye, Christopher
    Marques-Souza, Henrique
    Marques, Rafael E.
    LANCET MICROBE, 2021, 2 (10): : E527 - E535
  • [5] Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variants
    Zou, Lirong
    Zhang, Huan
    Zheng, Zhonghua
    Jiang, Yushan
    Huang, Yushi
    Lin, Shujian
    Yu, Jianxiang
    Deng, Xiaoling
    He, Jianfeng
    Shen, Chenguang
    Li, Baisheng
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (12) : 6065 - 6072
  • [6] Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
    Romanee Chaiwarith
    Poramed Winichakoon
    Parichat Salee
    Tavitiya Sudjaritruk
    Jiraprapa Wipasa
    Kriangkrai Chawansuntati
    Saowaluck Yasri
    Harit Thongwitokomarn
    Kawisara Krasaewes
    Sethawut Ruangsirinusorn
    Jutarat Praparattanapan
    Nuttarika Solai
    Khanuengnit Nuket
    Darakorn Boonmee
    Orapin Chaichana
    Oramai Mueangmo
    Jutamad Saheng
    Worawan Wongjak
    Scientific Reports, 13
  • [7] Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
    Chaiwarith, Romanee
    Winichakoon, Poramed
    Salee, Parichat
    Sudjaritruk, Tavitiya
    Wipasa, Jiraprapa
    Chawansuntati, Kriangkrai
    Yasri, Saowaluck
    Thongwitokomarn, Harit
    Krasaewes, Kawisara
    Ruangsirinusorn, Sethawut
    Praparattanapan, Jutarat
    Solai, Nuttarika
    Nuket, Khanuengnit
    Boonmee, Darakorn
    Chaichana, Orapin
    Mueangmo, Oramai
    Saheng, Jutamad
    Wongjak, Worawan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2 (Apr, 10.1016/S2666-5247(21)00082-3, 2021)
    Huang, B.
    Dai, L.
    Wang, H.
    LANCET MICROBE, 2021, 2 (07): : E288 - E288
  • [9] Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the Philippines
    Yu, J. N.
    Angeles, C. B.
    Lim, H. G.
    Chavez, C.
    Roxas-Rosete, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (12) : E841 - E845
  • [10] Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
    Urbanowicz, Richard A.
    Tsoleridis, Theocharis
    Jackson, Hannah J.
    Cusin, Lola
    Duncan, Joshua D.
    Chappell, Joseph G.
    Tarr, Alexander W.
    Nightingale, Jessica
    Norrish, Alan R.
    Ikram, Adeel
    Marson, Ben
    Craxford, Simon J.
    Kelly, Anthony
    Aithal, Guruprasad P.
    Vijay, Amrita
    Tighe, Patrick J.
    Ball, Jonathan K.
    Valdes, Ana M.
    Ollivere, Benjamin J.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (609)
12345